These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3940654)

  • 21. Prospective malignancy grading, flow cytometry DNA-measurements and adjuvant chemotherapy for invasive squamous cell carcinoma of the uterine cervix.
    Willén R; Himmelmann A; Långström-Einarsson E; Fernö M; Ranstam J; Baldetorp B; Skjaerris J; Prien-Larsen J; Tropé C; Stendahl U
    Anticancer Res; 1993; 13(4):1187-96. PubMed ID: 8352543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
    Gadducci A; Tana R; Cosio S; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Apr; 66(1):10-20. PubMed ID: 17964182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is T-cell activation an unfavourable sign in i.v.-drug addicts infected with HIV?
    Fuchs DN; Hausen A; Hengster P; Reibnegger GJ; Unterweger B; Werner ER; Hinterhuber H; Dierich MP; Wachter H
    Cancer Detect Prev; 1988; 12(1-6):277-82. PubMed ID: 3263196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neopterin as a new biochemical marker in the clinical assessment of ulcerative colitis.
    Niederwieser D; Fuchs D; Hausen A; Judmaier G; Reibnegger G; Wachter H; Huber C
    Immunobiology; 1985 Nov; 170(4):320-6. PubMed ID: 4086044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neopterin, a new biochemical marker for the detection of activated T lymphocytes].
    Niederwieser D; Huber C; Wachter H
    Wien Klin Wochenschr; 1983 Mar; 95(5):161-4. PubMed ID: 6602425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.
    Kim YB; Kim GE; Cho NH; Pyo HR; Shim SJ; Chang SK; Park HC; Suh CO; Park TK; Kim BS
    Cancer; 2002 Aug; 95(3):531-9. PubMed ID: 12209745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
    Xiong Y; Liang LZ; Zheng M; Wei M; Shen Y
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):29-33. PubMed ID: 17331418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary neopterin in the diagnosis and follow-up of neoplasia: a biochemical parameter to detect cell-mediated immune response.
    Fuchs D; Hausen A; Huber C; Reibnegger G; Wachter H
    Tumour Biol; 1984; 5(3-4):199-209. PubMed ID: 6505550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
    Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
    Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer.
    Gadducci A; Ferdeghini M; Malagnino G; Prontera C; Fanucchi A; Annicchiarico C; Bianchi R; Fioretti P; Facchini V
    Gynecol Oncol; 1994 Mar; 52(3):386-91. PubMed ID: 8157196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A simple index relating clinical activity in Crohn's disease with T cell activation: hematocrit, frequency of liquid stools and urinary neopterin as parameters.
    Reibnegger G; Bollbach R; Fuchs D; Hausen A; Judmaier G; Prior C; Rotthauwe HW; Werner ER; Wachter H
    Immunobiology; 1986 Oct; 173(1):1-11. PubMed ID: 3492436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neopterin, a marker of cell-mediated immune activation in human pregnancy.
    Fuith LC; Fuchs D; Hausen A; Hetzel H; Reibnegger G; Werner ER; Wachter H
    Int J Fertil; 1991; 36(6):372-5. PubMed ID: 1684963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone.
    Grigiene R; Valuckas KP; Aleknavicius E; Kurtinaitis J; Letautiene SR
    BMC Cancer; 2007 Dec; 7():234. PubMed ID: 18154683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neopterin and its importance in clinical diagnosis].
    Melichar B
    Cas Lek Cesk; 1994 Aug; 133(15):455-8. PubMed ID: 8082110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Liberation of neopterin after lung resecting interventions with and without bronchial carcinoma].
    Gebhard F; Lenz J; Brückner UB
    Chirurg; 1996 Jul; 67(7):725-9. PubMed ID: 8776545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of urinary neopterine in gynecological oncology: follow-up of patients with ovarian cancer.
    Hetzel H; Bichler A; Fuchs D; Hausen A; Reibnegger G; Wachter H
    Cancer Detect Prev; 1983; 6(1-2):263-6. PubMed ID: 6883385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection].
    Antón F; Labarga P; Pinilla J; Soto MJ; Leoz A; del Cura J; Borque L; Milazzo A
    Enferm Infecc Microbiol Clin; 1993; 11(7):373-7. PubMed ID: 8104488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of the immune parameter neopterin in adnexitis].
    Marth C; Windbichler G; Fuchs D; Zeimet AG; Wachter H; Dapunt O
    Zentralbl Gynakol; 1996; 118(3):164-8. PubMed ID: 8900606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pretreatment proliferation parameters do not add predictive power to clinical factors in cervical cancer treated with definitive radiation therapy.
    Tsang RW; Juvet S; Pintilie M; Hill RP; Wong CS; Milosevic M; Chapman W; Levin W; Manchul LA; Fykes AW
    Clin Cancer Res; 2003 Oct; 9(12):4387-95. PubMed ID: 14555510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.